Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.59 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.59 |
| ▸ | TRPM8 | Q7Z2W7 | 9/20 | 0.58 |
| ▸ | FAAH | O00519 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8022912 | 1.00 | LPAR3 (0.59) | LPAR3LPAR2TRPM8FAAHHPGD | |
| SCHEMBL6033209 | 1.00 | LPAR3 (0.59) | LPAR3LPAR2TRPM8FAAHHPGD | |
| SCHEMBL8330078 | 1.00 | LPAR3 (0.59) | LPAR3LPAR2TRPM8FAAHHPGD | |
| SCHEMBL10936078 | 1.00 | LPAR3 (0.59) | LPAR3LPAR2TRPM8FAAHHPGD | |
| SCHEMBL1727076 | 1.00 | LPAR3 (0.59) | LPAR3LPAR2TRPM8FAAHHPGD | |
| SCHEMBL10558343 | 1.00 | LPAR3 (0.59) | LPAR3LPAR2TRPM8FAAHHPGD | |
| SCHEMBL10556927 | 1.00 | LPAR3 (0.59) | LPAR3LPAR2TRPM8FAAHHPGD | |
| SCHEMBL25323220 | 0.97 | LPAR3 (0.62) | LPAR3LPAR2TRPM8FAAHTSHR | |
| SCHEMBL18964 | 0.97 | LPAR3 (0.62) | LPAR3LPAR2TRPM8FAAHTSHR | |
| SCHEMBL1230960 | 0.97 | LPAR3 (0.62) | LPAR3LPAR2TRPM8FAAHTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2403642-B1 | METHODS OF USING A SELECTIVE HYDROGENATION CATALYST | CHEVRON PHILLIPS CHEMICAL CO LP (US) | 2017-08-02 | — | — | EP | claimed |
| EP-3144064-B1 | SELECTIVE HYDROGENATION CATALYST AND METHODS OF MAKING AND USING SAME | CHEVRON PHILLIPS CHEMICAL CO LP (US) | 2021-07-28 | — | — | EP | disclosed |
| EP-3377596-A1 | SELECTIVE HYDROGENATION USING A FLOW INDEX | Chevron Phillips Chemical Company LP (US) | 2018-09-26 | — | — | EP | disclosed |
| CN-108291157-A | Selective hydrogenation using flow index | 切弗朗菲利浦化学公司 | 2018-07-17 | — | — | CN | disclosed |
| US-20180148260-A1 | Selective Hydrogenation Using a Flow Index | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2018-05-31 | — | — | US | disclosed |
| US-9914676-B2 | Selective hydrogenation using a flow index | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2018-03-13 | — | — | US | disclosed |
| US-20170349507-A1 | Selective Hydrogenation Using a Flow Index | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2017-12-07 | — | — | US | disclosed |
| EP-3218104-A1 | SELECTIVE HYDROGENATION CATALYST AND METHODS OF MAKING AND USING SAME | Chevron Phillips Chemical Company LP (US) | 2017-09-20 | — | — | EP | disclosed |
| US-9758446-B2 | Selective hydrogenation using a flow index | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2017-09-12 | — | — | US | disclosed |
| CN-107107049-A | Selective hydrogenation catalyst and its preparation and application | 切弗朗菲利浦化学公司 | 2017-08-29 | — | — | CN | disclosed |
| US-8633127-B2 | Selective hydrogenation catalyst and methods of making and using same | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2014-01-21 | — | — | US | disclosed |
| WO-2012177602-A1 | PRODUCTION OF HYDROXY ETHER HYDROCARBONS BY VAPOR PHASE HYDROGENOLYSIS OF CYCLIC ACETALS AND KETALS | EASTMAN CHEMICAL COMPANY (US) | 2012-12-27 | — | — | WO | disclosed |
| WO-2012177484-A1 | CATALYSTS FOR THE PRODUCTION OF HYDROXY ETHER HYDROCARBONS BY VAPOR PHASE HYDROGENOLYSIS OF CYCLIC ACETALS AND KETALS | EASTMAN CHEMICAL COMPANY (US) | 2012-12-27 | — | — | WO | disclosed |
| US-20120330067-A1 | CATALYSTS FOR THE PRODUCTION OF HYDROXY ETHER HYDROCARBONS BY VAPOR PHASE HYDROGENOLYSIS OF CYCLIC ACETALS AND KETALS | EASTMAN CHEMICAL COMPANY (US) | 2012-12-27 | — | — | US | disclosed |
| US-20120330066-A1 | PRODUCTION OF HYDROXY ETHER HYDROCARBONS BY VAPOR PHASE HYDROGENOLYSIS OF CYCLIC ACETALS AND KETALS | EASTMAN CHEMICAL COMPANY (US) | 2012-12-27 | — | — | US | disclosed |
| CN-102341175-A | Selective hydrogenation catalyst and methods of making and using same | CHEVRON PHILLIPS CHEMICAL CO | 2012-02-01 | — | — | CN | disclosed |
| EP-2403642-A2 | SELECTIVE HYDROGENATION CATALYST AND METHODS OF MAKING AND USING SAME | Chevron Phillips Chemical Company LP (US) | 2012-01-11 | — | — | EP | disclosed |
| WO-2010101736-A2 | SELECTIVE HYDROGENATION CATALYST AND METHODS OF MAKING AND USING SAME | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2010-09-10 | — | — | WO | disclosed |
| US-20100228065-A1 | Selective Hydrogenation Catalyst and Methods of Making and Using Same | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2010-09-09 | — | — | US | disclosed |
| US-5892121-A | Purification of tertiary phosphine oxides | BASF AKTIENGESELLSCHAFT (DE) | 1999-04-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120330067-A1 | CATALYSTS FOR THE PRODUCTION OF HYDROXY ETHER HYDROCARBONS BY VAPOR PHASE HYDROGENOLYSIS OF CYCLIC ACETALS AND KETALS | SUV39H2, KAT5, SUV39H1 | LPAR3 1195/4885LPAR2 1111/4885TRPM8 2396/4885 |
| US-20120330066-A1 | PRODUCTION OF HYDROXY ETHER HYDROCARBONS BY VAPOR PHASE HYDROGENOLYSIS OF CYCLIC ACETALS AND KETALS | SUV39H1, HDHD5, SUV39H2 | LPAR3 2566/4885LPAR2 2381/4885TRPM8 3150/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.